default author photo

John Hural

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division

Seattle, WA 98109-1024

United States

SCHOLARLY PAPERS

5

DOWNLOADS

464

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Hybrid Versus Vaccine Immunity of mRNA-1273 Among People Living with HIV in East and Southern Africa: The Multicentre, Open-Label COVPN 3008 (Ubuntu) Clinical Trial

Number of pages: 32 Posted: 11 Jul 2024
Centre for the AIDS Programme of Research in Africa (CAPRISA), University of KwaZulu- Natal, University of Washington, Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Public Health, Malawi, Fred Hutchinson Cancer Research Center, University of Zimbabwe, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Duke University - Department of Surgery, Fred Hutchinson Cancer Research Center, Chris Hani Baragwanath Academic Hospital, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, University of KwaZulu-Natal, University of KwaZulu-Natal - School of Laboratory Medicine and Medical Sciences, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, National Institutes of Health, National Institutes of Health, COVID-19 Prevention Network, University of Zimbabwe - Faculty of Medicine and Health Sciences, Baylor College of Medicine, Botswana Harvard AIDS Institute Partnership (BHP), Centre for Infectious Disease Research in Zambia, Columbia University - ICAP, Wits University - Clinical HIV Research Unit, Aurum Institute, Synexus Helderberg, University of Cape Town Lung Institute, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), TASK, FAMCRU Family Clinical Research Unit, University of Cape Town (UCT), Aurum Institute, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, Center for Family Health Research Zambia (CFHRZ), The Aurum Institute, Aurum Institute, South African Medical Research Council, UNC Global Projects, Soweto Clinical Trials Centre, Blantyre District Council, Center for Family Health Research Zambia (CFHRZ), Wits Health Consortium - Perinatal HIV Research Unit (PHRU), Synergy Biomed Research Institute, MERC Middelburg, Kisumu Clinical Research Site, TASK, TASK, Aurum Institute, Nelson Mandela Academic Clinical Research Unit Clinical Research Site, University of the Witwatersrand - Perinatal HIV Research Unit, Joint Clinical Research Centre, University of KwaZulu-Natal, South African Medical Research Council, Soweto Clinical Trials Centre, UVRI-IAVI HIV Vaccine Program, MeCRU Clinical Research Site, Maseno University, Synexus Stanza Clinical Research Centre Clinical Research Site, University of KwaZulu-Natal, PHOENIX Pharma (Pty) Ltd, Moi University, University of Cape Town (UCT), MERC Kempton, MERC Welkom, MU-JHU Care Ltd - MUJHU Research Collaboration, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Cape Town (UCT) - Desmond Tutu HIV Centre, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, South African Medical Research Council, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Qhakaza Mbokodo Research Clinic and Independent
Downloads 114 (621,766)

Abstract:

Loading...

People living with HIV, SARS-CoV-2, mRNA-1273, hybrid immunity, vaccine immunity, COVID-19

2.

SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 Study

Number of pages: 25 Posted: 11 Nov 2024
University of Washington, Fred Hutchinson Cancer Research Center, University of Cape Town (UCT), Fred Hutchinson Cancer Research Center, National Institutes of Health, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Washington - Department of Laboratory Medicine and Microbiology, Emory University - Division of Infectious Diseases, Emory University, Emory University, Federal University of Minas Gerais (UFMG), Fundación Huésped, Aurum Institute, Botswana Harvard AIDS Institute Partnership (BHP), University of Zimbabwe, University of Zimbabwe, Parirenyatwa Group of Hospitals, Hospital JM Ramos, Universidad Nacional de la Amazonía Peruana, The Aurum Institute, University of North Carolina (UNC) at Chapel Hill, Asociacion Civil Impacta Salud y Educacion, Universidad Nacional Mayor de San Marcos, Center for Family Health Research Zambia (CFHRZ), Ministry of Health Zambia - Zambia National Public Health Institute, MeCRU Clinical Research Site, Columbia University, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), Aurum Institute, Setshaba Research Centre, Bio Analytical Research Corporation South Africa (BARC SA), University of Washington, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center
Downloads 111 (635,347)

Abstract:

Loading...

COVID-19, COVID, host demographics, viral shedding, viral load, CoVPN 5001

3.

Pharmacokinetic Serum Concentrations of VRC01 Correlate with Prevention of HIV-1 Acquisition

Number of pages: 35 Posted: 18 Oct 2022
Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University, Duke University - School of Medicine, Duke University - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Independent, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington, University of Cape Town (UCT) - Institute of Infectious Disease and Molecular Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Biostatistics, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, FHI 360 (Family Health International), Via Libre CRS, University of California, Los Angeles (UCLA) - Department of Medicine, Wits Health Consortium - Perinatal HIV Research Unit (PHRU), University of Cape Town (UCT) - Department of Medicine, University of Pennsylvania, Asociacion Civil Impacta Salud y Educacion, Emory University - School of Medicine, San Miguel Clinical Research Center - Asociacion Civil Impacta Salud y Educacion, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, National Institute for Communicable Diseases of the National Health Laboratory Service, Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology
Downloads 98 (699,299)

Abstract:

Loading...

body weight, HIV, prevention, broadly neutralizing antibodies, monoclonal antibody, pharmacokinetics

4.

Lower SARS-CoV-2-Specific Humoral Immunity in People Living With HIV-1 Recovered From Symptomatic Non-Hospitalized COVID-19

Number of pages: 44 Posted: 04 Jan 2022
affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - School of Medicine, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Pennsylvania - Department of Medicine, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology and affiliation not provided to SSRN
Downloads 95 (714,876)

Abstract:

Loading...

HIV-1, PLWH, People Living with HIV, SARS-CoV-2, COVID-19, humoral immunity, antibody, antibody isotype, antibody subclass, ACE-2 blocking, ADCP, antibody dependent phagocytosis, Multiplex assay, Meso Scale Discovery, IgG, IgG1, IgG3, IgA, CoVPN

5.

Infusion Reactions in Persons Receiving the Broadly Neutralizing Antibody VRC01 or Placebo for Reduction of HIV-1 Acquisition: Results From the Phase 2b Antibody Mediated Prevention (AMP) Randomized Trials

Number of pages: 30 Posted: 14 May 2021
Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Emory University - School of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, National Institutes of Health - Vaccine Research Center, Botswana Harvard AIDS Institute Partnership (BHP), University of Cape Town (UCT) - Institute of Infectious Disease and Molecular Medicine, South African Medical Research Council, Asociacion Civil Impacta Salud y Educacion, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), Harvard University - Brigham and Women’s Hospital, FHI 360 (Family Health International), Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center, Aurum Institute and University of Zimbabwe - Clinical Trials Research Centre
Downloads 46 (1,108,890)

Abstract:

Loading...

infusion related reactions, hypersensitivity, broadly neutralizing antibodies, AMP study, HIV